122 related articles for article (PubMed ID: 10220823)
1. [Contraindicated medical references and vasoactive agents in arterial pathology of the lower limbs].
Boccalon H
Rev Med Interne; 1999 Jan; 20(1):68-73. PubMed ID: 10220823
[TBL] [Abstract][Full Text] [Related]
2. [Microcirculation in peripheral arterial occlusive diseases will improve. Prostaglandin can prevent surgery].
MMW Fortschr Med; 2003 Dec; 145(51-52):41. PubMed ID: 14974333
[No Abstract] [Full Text] [Related]
3. [New data on vasoactive drug. Patients with peripheral arterial occlusive disease walk twice as long].
MMW Fortschr Med; 2002 May; 144(21):54. PubMed ID: 12134429
[No Abstract] [Full Text] [Related]
4. Comparison between intravenous iloprost and vasoactive drugs in limb ischemia IIB severe. A retrospective analysis.
Di Salvo MM; Ardita G; Giani L; Mugno F; Stevenazzi F; Mazzone A
Minerva Cardioangiol; 2006 Jun; 54(3):377-81. PubMed ID: 16733512
[TBL] [Abstract][Full Text] [Related]
5. [Vasoactive agents and prostanoids in the therapy of PAD: facts, questions, disproven assumptions].
Heidrich H
Hamostaseologie; 2006 Aug; 26(3):220-3. PubMed ID: 16906239
[TBL] [Abstract][Full Text] [Related]
6. [Tolerance and therapeutic results of iloprost in obliterative arteriopathy in lower limbs at the severe chronic ischemia stage. A retrospective study of 29 consecutive cases].
Duthois S; Cailleux N; Lévesque H
J Mal Vasc; 2000 Feb; 25(1):17-26. PubMed ID: 10705132
[TBL] [Abstract][Full Text] [Related]
7. Combined percutaneous endovascular iliac angioplasty and infrainguinal surgical revascularization for chronic lower extremity ischemia: preliminary result.
Mousa A; Abdel-Hamid M; Ewida A; Saad M; Sahrabi A
Vascular; 2010; 18(2):71-6. PubMed ID: 20338130
[TBL] [Abstract][Full Text] [Related]
8. [Survey on adherence to hygiene and dietary rules in patients with arterial occlusive disease].
Aligne C; Mosnier M; Mistretta F; Larguier JS
J Mal Vasc; 2000 Jun; 25(3):187-94. PubMed ID: 10906634
[TBL] [Abstract][Full Text] [Related]
9. Buflomedil in arterial occlusive disease: results of a controlled multicenter study.
Trübestein G; Balzer K; Bisler H; Klüken N; Muller-Wiefel H; Unkel B; Mahfoud Y; Ziegler W
Angiology; 1984 Aug; 35(8):500-5. PubMed ID: 6383127
[TBL] [Abstract][Full Text] [Related]
10. [Buflomedil in arterial occlusive disease. Results of a controlled study].
Trübestein G; Balzer K; Bisler H; Klüken N; Mahfoud Y; Müller-Wiefel H; Unkel B; Ziegler W
Dtsch Med Wochenschr; 1982 Dec; 107(51-52):1957-61. PubMed ID: 6756854
[No Abstract] [Full Text] [Related]
11. [Changes in prescription patterns for peripheral and cerebral vasoactive drugs before and after establishing prescription standards in France].
Vuittenez F; Guignard E; Comte S
Presse Med; 1999 Jan; 28(3):122-6. PubMed ID: 10026716
[TBL] [Abstract][Full Text] [Related]
12. When is urokinase treatment an effective sole or adjunctive treatment for acute limb ischemia secondary to native artery occlusion?
Suggs WD; Cynamon J; Martin B; Sanchez LA; Wahl SI; Aronoff B; Veith FJ
Am J Surg; 1999 Aug; 178(2):103-6. PubMed ID: 10487258
[TBL] [Abstract][Full Text] [Related]
13. Silence of the limbs pharmacological symptomatic treatment of intermittent claudication.
De Backer T; Vander Stichele R; De Buyzere M; De Backer G; Van Bortel L
Curr Vasc Pharmacol; 2010 May; 8(3):383-7. PubMed ID: 19485897
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effects of exercise beyond the pain threshold in intermittent claudication.
Carlon R; Morlino T; Maiolino P
Ital Heart J; 2003 Feb; 4(2):113-20. PubMed ID: 12762274
[TBL] [Abstract][Full Text] [Related]
15. Medical treatment of peripheral vascular disease: good or bad?
Duprez D; Clement DL
Eur Heart J; 1992 Feb; 13(2):149-51. PubMed ID: 1555609
[TBL] [Abstract][Full Text] [Related]
16. A randomized trial of iloprost in patients with intermittent claudication.
Creager MA; Pande RL; Hiatt WR
Vasc Med; 2008 Feb; 13(1):5-13. PubMed ID: 18372433
[TBL] [Abstract][Full Text] [Related]
17. Trial of a novel prostacyclin analog, UT-15, in patients with severe intermittent claudication.
Mohler ER; Klugherz B; Goldman R; Kimmel SE; Wade M; Sehgal CM
Vasc Med; 2000; 5(4):231-7. PubMed ID: 11213235
[TBL] [Abstract][Full Text] [Related]
18. Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease.
Böger RH; Bode-Böger SM; Thiele W; Creutzig A; Alexander K; Frölich JC
J Am Coll Cardiol; 1998 Nov; 32(5):1336-44. PubMed ID: 9809945
[TBL] [Abstract][Full Text] [Related]
19. [Shunt effect in iloprost treatment of obliterative arteriopathy].
Vannucchi PL; Polignano R; Becucci P; Milli M
Minerva Cardioangiol; 1999 Dec; 47(12):654-5. PubMed ID: 10670247
[No Abstract] [Full Text] [Related]
20. [Medical treatment of obliterating arteriopathies of the lower limbs with vasoactive drugs].
Raspanti D; Cameli AM; Trapani M; Dorigo D; Mazzotta A; Negro P
Clin Ter; 1987 Jun; 121(6):479-83. PubMed ID: 2973884
[No Abstract] [Full Text] [Related]
[Next] [New Search]
